1. Home
  2. ELA vs BDTX Comparison

ELA vs BDTX Comparison

Compare ELA & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envela Corporation

ELA

Envela Corporation

HOLD

Current Price

$12.09

Market Cap

334.4M

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

116.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELA
BDTX
Founded
1965
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.4M
116.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
ELA
BDTX
Price
$12.09
$2.18
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$11.50
$10.20
AVG Volume (30 Days)
65.2K
585.3K
Earning Date
01-01-0001
06-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
130.71
EPS
0.33
0.39
Revenue
$180,376,229.00
N/A
Revenue This Year
$19.13
N/A
Revenue Next Year
$2.46
N/A
P/E Ratio
$36.91
$5.72
Revenue Growth
2.92
N/A
52 Week Low
$5.10
$1.20
52 Week High
$15.11
$4.94

Technical Indicators

Market Signals
Indicator
ELA
BDTX
Relative Strength Index (RSI) 40.49 43.97
Support Level $11.30 $1.93
Resistance Level $13.87 $2.86
Average True Range (ATR) 0.84 0.14
MACD -0.15 -0.00
Stochastic Oscillator 10.19 40.50

Price Performance

Historical Comparison
ELA
BDTX

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: